Aditxt Inc
0.11 (7.64%)
Company Name Stock Ticker Symbol Market Type
Aditxt Inc ADTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.11 7.64% 1.55 19:56:44
Open Price Low Price High Price Close Price Prev Close
1.46 1.4101 1.6481 1.515 1.44
more quote information »

Recent News

Date Time Source Heading
1/20/202316:31EDGARCurrent Report Filing (8-k)
1/06/202316:16EDGARCurrent Report Filing (8-k)
1/04/202308:01EDGARStatement of Ownership (sc 13g)
1/03/202309:00BWAditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with..
12/23/202216:31EDGARCurrent Report Filing (8-k)
12/20/202209:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/20/202209:13EDGARCurrent Report Filing (8-k)
12/02/202216:32EDGARCurrent Report Filing (8-k)
11/14/202216:07EDGARQuarterly Report (10-q)
10/21/202216:22EDGARProxy Statement (definitive) (def 14a)
10/21/202209:00BWAditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the..
10/12/202209:00BWAditxt, Inc. (Nasdaq: ADTX) Announces Development and..
10/07/202209:00BWFedEx Features AditxtScore™ Immune Monitoring Center and its..
10/03/202216:32EDGARCurrent Report Filing (8-k)
9/29/202209:00BWAditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained..
9/27/202215:35EDGARStatement of Ownership (sc 13g)
9/27/202209:00BWAditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights..
9/26/202206:21EDGARStatement of Ownership (sc 13g)
9/20/202216:59EDGARCurrent Report Filing (8-k)
9/20/202216:09BWAditxt Announces Closing of $20.0 Million Public Offering
9/20/202209:16EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
9/19/202206:02EDGARNotice of Effectiveness (effect)
9/16/202209:20BWAditxt Announces Pricing of $20.0 Million Public Offering
9/16/202208:47EDGARSecurities Registration Statement (s-1/a)
9/15/202216:03EDGARSecurities Registration Statement (s-1/a)
9/15/202206:33EDGARSecurities Registration Statement (s-1/a)
9/14/202206:31EDGARCurrent Report Filing (8-k)
9/13/202216:15BWAditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock..
8/26/202216:17EDGARCurrent Report Filing (8-k)
8/17/202216:16EDGARSmall Company Offering and Sale of Securities Without..
8/15/202216:14EDGARQuarterly Report (10-q)
8/15/202216:02EDGARRevised Proxy Soliciting Materials (definitive) (defr14a)
8/10/202216:16EDGARCurrent Report Filing (8-k)
8/02/202208:17GLOBEIBN (InvestorBrandNetwork) Announces Latest Episode of The..
8/01/202208:13EDGARProxy Statement (definitive) (def 14a)
7/26/202217:25EDGARCurrent Report Filing (8-k)
7/21/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
7/20/202217:00EDGARProxy Statement - Notice of Shareholders Meeting..
7/08/202216:35EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/08/202216:19EDGARCurrent Report Filing (8-k)
7/08/202208:30BWAditxt, Inc. Successfully Completes Preclinical Toxicity..
6/28/202216:14EDGARCurrent Report Filing (8-k)
6/16/202216:04EDGARFiling of Certain Prospectuses and Communications in..
6/16/202216:01EDGARCurrent Report Filing (8-k)
6/15/202214:40EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/15/202209:25EDGARCurrent Report Filing (8-k)
6/14/202214:00PRNUSPremier Medical Laboratory Services Now Offering..
6/03/202216:30EDGARCurrent Report Filing (8-k)
5/16/202216:25EDGARQuarterly Report (10-q)
5/04/202217:44BWADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates..